Bio Job Blog : Bio Jobs : Biotechnology Jobs : Biopharmaceutical Jobs : Bioscience, Biotech Jobs : Bio Job Blog : Biocareer : Bio-Business Training, Biotechnology Training : Jobs in Biology : Internships in Biology : Internships in Biotechnology

While the debate rages on over the use of social media in the life sciences industry, industry experts and insiders have largely ignored the growing importance of mobile healthcare and its use by healthcare professionals and patients. Consumers and professionals are increasingly using their mobile devices for healthcare information. They are also interacting with healthcare providers and colleagues on their mobile phones. 85% of US consumers have cell phones and growing vs. only 65% of Americans which have broadband access. Further, the divide between mobile use and broadband Internet access is increasing. According to a Manhattan Research report 70% of Physicians say PDAs/Smartphones are "essential" to their practice.

Because of the growing importance of mobile healthcare communications, the Manhattan-based Business Development Institute decided to organize a conference around this theme. The primary goal of the conference is to address the following questions:

1. How do healthcare brands connect and interact with consumers via mobile strategies?
2. How do healthcare brands connect and interact with healthcare professionals via mobile strategies?
3. What are the leading technologies being used for mobile strategies?
4. How do you deal with regulatory hurdles when implementing mobile campaigns?
5. How do you integrate your mobile strategies into your enterprise-wide marketing, communications and social media platforms?
6. What are the leading monitoring and measuring approaches/technologies being employed for mobile campaigns?

Person giving presentations at the meeting include:

Lance Hill, CEO, Within3
Ray Kerins, Vice President/Worldwide Communications, Pfizer Inc.
Marc Monseau, Director, Corporate Communications and Social Media, Johnson & Johnson
Todd Siesky, Public Relations Manager, Roche Diabetes Care
 
Date: Wednesday, January 19, 2011
Time: 8:00 a.m. - 1:00 p.m.
Location: The Graduate Center of The City University of NY; 365 Fifth Avenue; New York, New York 10016
Registration Fee: $195
Website:http://www.bdionline.com/mobilehealthcare.html

For more information, including registration, please click here to visit the event website. Use promo code BC for a discounted rate of $155.

Please contact Steve Etzler at setzler@bdionline.com or 212-765-8045 for additional information.

See you at the meeting!

Until next time...

Good Luck and Good Job Hunting!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

What a difference six months can make in the fast moving world of the social web! At last May’s Advanced Learning Institute’s conference on “Social Media for Pharma” there was a lot of anxiety, hand wringing and concern about the future of social media in the life sciences industry. 

Things were much different at “Social Media for Pharma” (also sponsored by the Advance Learning Institute) held earlier this week in Manhattan. Like last May’s meeting, there was still much speculation about when the US Food and Drug Administration (FDA) may provide the much awaited regulatory guidance on the use of social media for promotional purposes in the pharmaceutical industry. And, despite a presentation by FDA representatives at the meeting—that somewhat paradoxically described how the agency was using social media tools like Twitter, YouTube and Facebook to better educate and inform the American public about its activities and services —there were no hints about when the agency may issuing that guidance. Nevertheless, the number of pharma and biotechnology companies that have decided to “take the plunge into the social media pool” has grown substantially since last May. In fact, I got the sense that many of the conference participants were beginning to believe that implementing social media strategies was possible even if the agency fails to issue the long awaited guidance!

Generally speaking, there was a growing consensus at the meeting that the use of social media for promotional purposes—specifically to bolster sales of approved and marketed drugs and devices—may not be its best use. Several presentations, most notably those offered by Justin Gardener and Lindsey Hart from Advanced BioHealing, Inc and Jenny Keeney from Astellas Pharma US, Inc showed how social media can be used by life sciences companies to improve healthcare outcomes for patients and promote science education to improve the public understanding of science. Nancy Buono Cartwright from Kaiser Permanente gave a great talk on how to use social media to enhance corporate communication and employee participation and retention. 

A panel discussion featuring Dennis Urbaniak, Sanofi Aventis, Cynthia Phillips, Millennium Pharmaceuticals, Inc and Justin Gardner, Advanced BioHealing, Inc and lead by John Mack aka the Pharma Guy was insightful and extremely illuminating regarding pharma’s changing attitudes toward social media. All of the panelists agreed that the drug industry is in transition and that now may be the time to try new things to get back to addressing unmet medical and patient needs. More importantly, Dennis Urbaniak stressed that pharma must begin to listen to what patients and stakeholders want rather than dictating or imposing “its” ideas and products on them. And, that it is apparent that social media provides an ideal vehicle to accomplish that goal.

Finally, Doug Levy, a compliance lawyer and Executive Director of Communications and Public Affairs Columbia Medical Center, gave an inspiring talk on how social media is no different than traditional modes of communication and that best practices already exist whether or not FDA ever issues any additional guidance on the topic! It appears that it is no longer a question of “if” but “when” as pharma continues to warm to inevitability of social media.

Until next time...

Good Luck and Good Tweeting or Whatever Your SM Tool of Choice May Be

• Email This
• Print
• Comments
• Trackbacks
• Share Link

The fourth BioConference Live: Clinical Diagnostics meeting will be taking place on October 20-21, 2010.   This online-only, live, interactive virtual event will cover new technologies, best practices and other pertinent topics for Clinical Diagnostics professionals. Registration is free and all interested persons can attend!  The conference is accredited by the ASCLS American Society for Clinical Laboratory Science and Professional Acknowledgment for Continuing Education (P.A.C.E.).

Therapeutic areas to be covered include: Infectious Diseases, Cancer, Diabetes, Allergy & Immunology, Cardiology, Point of Care, Automation, Molecular Diagnostics, Hematology, Laboratory Testing, Stem Cells, Protein Arrays, and Clinical Chemistry.

Some of the featured speakers include:

1. Alan Wu Ph.D., Chief of Clinical Chemistry & Toxicology & Prof. Laboratory Medicine, San Francisco General Hospital and University of California, San Francisco
2. Steven Burrill, CEO Burrill & Company
3. David Persing M.D. Ph.D., Chief Medical and Technology Officer, Cepheid
4. Peter Gilligan Ph.D., Professor of Microbiology-Immunology UNC Hospitals
5. Thomas Goodwin Ph.D., Project Scientist (NxPCM) and Director Disease Modeling & Tissue Analogues Laboratory NASA
6. Steven Binder, Director Technology Development Bio-Rad Laboratories
7. Brad Karon M.D., Ph.D., FCAP, FACB, Vice Chair of Education in the Department of Laboratory Medicine Mayo Clinic
8. Alex Rai Ph.D., Director, Specialty Laboratory, Chief Scientific Officer, Center for Advanced Laboratory Medicine, Columbia University
9. Robert Fitzgerald Ph.D., Associate Professor, University of California San Diego

Login will take place on October 20th and 21st between 9 AM and 6 PM EST.

Sign Up Now and have a chance to win an iPad if you refer a friend!

Until next time...

Good Luck and Good Learning!!!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

Last year, the first BioConference Live event was held. For those of you who may not have heard about BioConference Live, it is a free, online biotechnology and pharmaceutical event that features keynote speakers and live presentations, a lobby and even a virtual exhibit hall. The success of the inaugural meeting has prompted the conference promoters to organize a second BioConference Live event which will be held on June 2 & 3.

The June event will feature over 50 live keynote and seminar presentations and include topics such as cancer research, drug discovery, cell biology, genomics, proteomics, lab automation, bioinformatics, and infectious diseases. Some of the featured speakers include:David Wolf M.D. NASA Astronaut, Steven Burrill CEO of Burrill & Company, Kevin Hrusovsky, CEO of Caliper Life Sciences, and Paul Schoemaker, Ph.D. Chairman and CEO Decision Strategies International, Inc. To view the complete BioConference Live agenda click here. For a complete list of speakers click here

To learn more, and register for free, visit http://bioconferencelive.com/. If you register, attend, and recommend 3 friends, you can win an iPad.

I hope to see you (sort of) at the conference.

Until next time….

Good Luck and Good Job Hunting!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

NextLevel Pharma has organized several life sciences meetings that may be of interest to BioJobBlog readers. These include: a webinar entitled “Safety Biomarkers in Drug Development” on October 14 and 21, 2009; a conference, “Best Practices in Phase IV Clinical and Observational Research” December 3-4, 2009 in Prague, Czech Republic and “Advancing Biologics from the Lab to the Clinic", January 11-12, 2010 in Brussels, Belgium.

Each of these offerings offers ideas and insights into important issues that are emerging in the life sciences industry. Check it out!

Until next time....

Good Luck and Good Job Hunting!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link